Sudarshan Pharma Industries Ltd - 543828 - Intimation For Acquisition Of The Shares Of The Company (Wholly Owned Subsidiary) & Outcome Of The Meeting Of Board Of Directors Of The Company Held On August 02, 2023.
The Board of Directors at its meeting held on 02nd August, 2023 approved the Agenda contained in the Outcome. Due to the restriction on the limit of the Chracters, the Outcome of the Board meeting is attached in the PDF Format for your records. Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Acquisition
The Board of Directors at its meeting held on 02nd August, 2023 approved the agenda contained in the Outcome. Due to the the restriction on the limit of the Characters. The outcome of the Board meeting is uploaded in the PDF Format for your records. Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Outcome for Intimation For Acquisition Of The Shares Of The Company (Wholly Owned Subsidiary) & Outcome Of The Meeting Of Board Of Directors Of The Company Held On August 02, 2023.
The Board of Directors at its meeting held on 02nd August, 2023 approved the agenda contained in the Outcome. Due to the restrictions on the Characters limit, the outcome of the Board meeting is attached in the PDF Format for your records. Sudarshan Pharma Industries Ltd - 543828 - Closure of Trading Window
Sudarshan Pharma Industries Limited hereby gives intimation to the stock exchange on closure of trading window. Sudarshan Pharma Industries Ltd - 543828 - Business Update Of Sudarshan Pharma Industries Limited.
Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about a Business Update on additional Information of the Company. Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On August 02, 2023.
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 ,inter alia, to consider and approve With reference to the captioned subject matter, Notice is hereby given that a Meeting of the Board of Directors of the company is scheduled to be held on Wednesday, August 02, 2023 at 02:00 PM, inter-alia, to consider and approve the following business: 1. To acquire 'RATNA LIFESCIENCES PRIVATE LIMITED' (herein after referred as a Company) as the Wholly-Owned Subsidiary. 2. To incorporate a Subsidiary Company. & to consider and discuss any other matter. Sudarshan Pharma Industries Ltd - 543828 - Confirmation Of Successfully Completion Of First Milestone In Development (R&D) & Manufacturing Sample Of Vitamin B6 (PYRIDOXINE HYDROCHLORIDE)' Finish API.
Sudarshan Pharma Industries hereby intimates to the Stoock Exchange about confirmation of sucessfully completion of First milestone in Development (R&D) and Manufacturing sample of Vitamin B6 (PYRIDOXINE HYDROCHLORIDE) finish API issued to the Company Sudarshan Pharma Industries Ltd - 543828 - Approval Of Application Under The Production Linked Incentive (PLI) Scheme.
Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Approval Letter under the Production Linked Incentive Scheme issued to the Company. Sudarshan Pharma Industries Ltd - 543828 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 in furtherance to our letter SPIL/CS/SE/2023-2024/04 , SPIL/CS/SE/2023-2024/05 and SPIL/CS/SE/2023-2024/06 dated 14.07.2023, 21.07.2023 and 26.07.2023 the Record date for the purpose of payment of Final Dividend would be August 26, 2023. Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Outcome for Revised Outcome
The Company intends to intimate to the Stock Exchange that with reference to the captioned subject matter, this letter is in continuation to the letter dated SPIL/CS/SE/2023-2024/05 to further inform you certain changes and that a Meeting of Board of Directors of the company was held on July 21, 2023